These results suggest that (i) CMTM6 is a mainstay of PD-L1 on the surface of cancer cells, and (ii) the other receptors also function cooperatively with CMTM6 to stabilize PD-L1 according to their expression status. This evidence concerns the gene CD274 and cancer.